HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT04895215

AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

Medication studyAges 5–17Multiple countriesAnxiety
The study in practice

Understand this study

Who was this study for?

Listed age limits: 5 years to 17 years.

Listed locations
Dothan and 23 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study clarity

Study information

Study start dateStarted: August 2, 2021
Recruitment status
Completed
Enrollment listed in the registry
156
Sponsor
Vertero Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Australia, New Zealand
Age range
From 5 Years to 17 Years
Official registry ID
NCT04895215
Official title
Show the full official title

A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of AB-2004 in an Autism Spectrum Disorder Population

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Dothan, United States · Phoenix, United States · Tucson, United States

20 more locations
  • San Rafael, United States
  • Westlake Village, United States
  • Centennial, United States
  • New Haven, United States
  • Jacksonville, United States
  • Orlando, United States
  • Tampa, United States
  • Naperville, United States
  • Columbia, United States
  • Las Vegas, United States
  • New York, United States
  • Orangeburg, United States
  • Columbus, United States
  • Nashville, United States
  • Dallas, United States
  • Sydney, Australia
  • South Brisbane, Australia
  • Clayton, Australia
  • Parkville, Australia
  • Grafton, New Zealand
Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Vertero Therapeutics.

Did this study involve medication?

Yes. The study involved medication, including AB-2004 and Placebo.

Who was this study for?

Listed age limits: 5 years to 17 years.

Want to explore more studies?

Explore studies